SCM
CYTK icon

Silverarc Capital Management’s Cytokinetics CYTK Stock Holding History

Silverarc Capital Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.69M Buy
+71,203
New +$4.53M 0.55% 44
2025
Q4 		– Sell
-211,000
Closed -$11.6M – 80
2025
Q3 		$11.6M Buy
+211,000
New +$8.69M 1.68% 20
2024
Q2 		– Sell
-50,000
Closed -$3.51M – 77
2024
Q1 		$3.51M Buy
+50,000
New +$3.87M 0.98% 32
2023
Q1 		– Sell
-17,500
Closed -$802K – 87
2022
Q4 		$802K Buy
+17,500
New +$753K 0.28% 73
2022
Q1 		– Sell
-58,190
Closed -$2.65M – 75
2021
Q4 		$2.65M Buy
58,190
+8,881
+18% +$343K 1.19% 31
2021
Q3 		$1.76M Buy
+49,309
New +$1.45M 1.02% 36

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return